---
figid: PMC9697024__pharmaceuticals-15-01442-g007
pmcid: PMC9697024
image_filename: pharmaceuticals-15-01442-g007.jpg
figure_link: /pmc/articles/PMC9697024/figure/pharmaceuticals-15-01442-f007/
number: Figure 7
figure_title: ''
caption: 'Apigenin reduces the expression levels of IL-6, P-JAK2, P-STAT3, and SOCS3
  in the kidneys of HUA mice. Representative images of IHC staining (×200, Scale bar:
  100 μm) and their analyses show IL-6 (A,B), P-JAK2 (C,D), and P-STAT3 (E,F) expressions
  in the kidneys (n = 5). Representative images of western blots and their analyses
  show IL-6 (G), P-JAK2 (H), P-STAT3 (I), and SOSC3 (J) expressions in the kidneys
  (n ≥ 3). ##p < 0.01, #p < 0.05 vs. the NC group. ** p < 0.01, * p < 0.05 vs. the
  HC group.'
article_title: Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation
  of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway.
citation: Tianyuan Liu, et al. Pharmaceuticals (Basel). 2022 Nov;15(11):1442.
year: '2022'

doi: 10.3390/ph15111442
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- hyperuricemia
- apigenin
- uric acid
- molecular docking
- JAK2/STAT3 signaling
- renal injury

---
